Evidence map›Paper›PMID 35644035›Full record

SynthesisArthritis & rheumatology (Hoboken, N.J.)2022

Risk Assessment for Hip and Knee Osteoarthritis Using Polygenic Risk Scores.

Bahar Sedaghati-Khayat, Cindy G Boer, Jos Runhaar, Sita M A Bierma-Zeinstra, Linda Broer, M Arfan Ikram, Eleftheria Zeggini, André G Uitterlinden, Jeroen G J van Rooij, Joyce B J van Meurs

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Arthritis & rheumatology (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Bahar Sedaghati-KhayatErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-7665-8648
Cindy G BoerErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jos RunhaarErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-6293-6707
Sita M A Bierma-ZeinstraErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Linda BroerErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
M Arfan IkramErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Eleftheria ZegginiInstitute of Translational Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany, and Technical University of Munich (TUM) and Klinikum Rechts der Isar, TUM School of Medicine, Munich, Germany.ORCID 0000-0003-4238-659X
André G UitterlindenErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jeroen G J van RooijErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Joyce B J van MeursErasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Erasmus MC · NLHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePolygenic risk scores (PRS) allow risk stratification using common single-nucleotide polymorphisms (SNPs), and clinical applications are currently explored for several diseases. This study was undertaken to assess the risk of hip and knee osteoarthritis (OA) using PRS.

methodsWe analyzed 12,732 individuals from a population-based cohort from the Rotterdam Study (n = 11,496), a clinical cohort (Cohort Hip and Cohort Knee [CHECK] study; n = 908), and a high-risk cohort of overweight women (Prevention of Knee OA in Overweight Females [PROOF] study; n = 328), for the association of the PRS with prevalence/incidence of radiographic OA, of clinical OA, and of total hip replacement (THR) or total knee replacement (TKR). The hip PRS and knee PRS contained 44 and 24 independent SNPs, respectively, and were derived from a recent genome-wide association study meta-analysis. Standardized PRS (with Z transformation) were used in all analyses.

resultsWe found a stronger association of the PRS for clinically defined OA compared to radiographic OA phenotypes, and we observed the highest PRS risk stratification for TKR/THR. The odds ratio (OR) per SD was 1.3 for incident THR (95% confidence interval [95% CI] 1.1-1.5) and 1.6 (95% CI 1.3-1.9) for incident TKR in the Rotterdam Study. The knee PRS was associated with incident clinical knee OA in the CHECK study (OR 1.3 [95% CI 1.1-1.5]), but not for the PROOF study (OR 1.2 [95% CI 0.8-1.7]). The OR for OA increased gradually across the PRS distribution, up to 2.1 (95% CI 1.4-3.2) for individuals with the 10% highest PRS compared to the middle 50% of the PRS distribution.

conclusionOur findings validated the association of PRS across OA definitions. Since OA is becoming frequent and primary prevention is not commonly applicable, PRS-based risk assessment could play a role in OA prevention. However, the utility of PRS is dependent on the setting. Further studies are needed to test the integration of genetic risk assessment in diverse health care settings.

Indexed as

Arthroplasty, Replacement, HipOsteoarthritis, HipOsteoarthritis, KneeFemaleGenome-Wide Association StudyHumansMultifactorial InheritanceOverweightRisk AssessmentRisk Factors

Identifiers

PMID35644035
PMCPMC9541521
OpenAlexW4282915660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.